Amylin Pharmaceuticals
From Wikipedia, the free encyclopedia
Amylin Pharmaceuticals | |
---|---|
Type | Public (NASDAQ: AMLN) |
Founded | 1987 |
Headquarters | San Diego, California |
Industry | Biotechnology |
Products | Symlin (pramlintide) Byetta (exenatide) |
Employees | 1550 [1] |
Website | http://amylin.com/ |
Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. Currently, Amylin produces two drugs, Symlin (pramlintide acetate) and Byetta (exenatide). Amylin also is working on producing a drug based on Leptin.[2] Amylin is part of the NASDAQ-100.